Fact Sheet, Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Fact Sheet    (ALKE)


REVEALED: How to Potentially Increase Your Monthly Income Without Working 24x7


Here is the latest financial fact sheet of . For more details, see the quarterly results and share price and chart. For a sector overview, read our pharmaceuticals sector report.

ALKEM LABORATORIES Price History

Price Rs 2,848.2
Mkt Cap Rs m 340,539
Vol '000 1.6
P/E X  
P/CF X 43.4
EPS (TTM) Rs 0.0
% ch % 2.0
No. of shares m 119.57
% ch week % 1.9
% ch 1-mth % 7.2
% ch 12-mth % 40.0
52 week H/L Rs 3,089.6/1,950.0
(As on Dec 3, 2020 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ALKEM LABORATORIES Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
ALKEM LABORATORIES EQUITY SHARE DATA
High RsNA1,589 
Low RsNA1,232 
Sales per share (Unadj.) Rs313.1417.5 
Earnings per share (Unadj.) Rs32.756.3 
Diluted earnings per shareRs32.856.3 
Cash flow per share (Unadj.) Rs38.764.7 
Dividends per share (Unadj.) Rs012.70 
Adj. dividends per shareRs0.0012.70 
Dividend yield (eoy) %NM0.9 
Book value per share (Unadj.) Rs250.8292.9 
Adj. book value per shareRs250.8292.9 
Shares outstanding (eoy) m119.57119.57 
Bonus/Rights/Conversions  -- 
Price / Sales ratio x03.4 
Avg P/E ratio x025.1 
P/CF ratio (eoy) x021.8 
Price / Book Value ratio x04.8 
Dividend payout %022.6 
Avg Mkt Cap Rs m0168,653 
No. of employees `000NANA 
Total wages/salary Rs m6,4599,171 
Avg. sales/employee Rs ThNMNM 
Avg. wages/employee Rs ThNMNM 
Avg. net profit/employee Rs ThNMNM 
ALKEM LABORATORIES INCOME DATA
Net Sales Rs m37,43449,915 
Other income Rs m1,8101,645 
Total revenues Rs m39,24451,561 
Gross profit Rs m4,2188,482 
Depreciation Rs m7091,006 
Interest Rs m811671 
Profit before tax Rs m4,5088,451 
Minority Interest Rs m0-114 
Prior Period Items Rs m00 
Extraordinary Inc (Exp) Rs m00 
Tax Rs m5921,606 
Profit after tax Rs m3,9166,731 
Gross profit margin %11.317.0 
Effective tax rate %13.119.0 
Net profit margin %10.513.5 
ALKEM LABORATORIES BALANCE SHEET DATA
Current assets Rs m23,38127,062 
Current liabilities Rs m20,06015,324 
Net working cap to sales %8.923.5 
Current ratio x1.21.8 
Inventory Days Days7667 
Debtors Days Days5141 
Net fixed assets Rs m11,42912,610 
Share capital Rs m239239 
"Free" reserves Rs m29,58834,490 
Net worth Rs m29,99135,027 
Long term debt Rs m3341,212 
Total assets Rs m52,95854,387 
Interest coverage x6.613.6 
Debt to equity ratio x00 
Sales to assets ratio x0.70.9 
Return on assets %8.913.6 
Return on equity %13.119.2 
Return on capital %17.524.9 
Exports to sales %9.212.9 
Imports to sales %3.93.1 
Exports (fob) Rs m3,4446,461 
Imports (cif) Rs m1,4561,540 
Fx inflow Rs m3,5166,563 
Fx outflow Rs m2,5903,012 
Net fx Rs m9263,552 
ALKEM LABORATORIES CASH FLOW
From Operations Rs m 3,255 7,259 
From Investments Rs m -2,370 1,864 
From Financial Activity Rs m -518 -9,273 
Net Cashflow Rs m 367 -150 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 66.9%
Foreign collaborators 0.0%
Indian inst/Mut Fund 33.1%
FIIs 0.0%
ADR/GDR 0.0%
Free float 0.0%
Shareholders 68,381
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Alkem House, Senapati Bapat Marg, Lower Parel, Mumbai-13
E-MAIL investors@alkem.com WEB www.alkemlabs.com
TELEPHONE 02239829999 FAX
SECTOR PHARMACEUTICALS GROUP
TR AGENT Link Intime India Pvt Ltd
CHM: Mr. Samprada Singh COMP SEC: Mr. Manish Narang YEAR OF INC: 1973 BSE CODE: 539523 FV (Rs): 2 DIV YIELD (%): 0.4

More Pharmaceuticals Company Fact Sheets:   PANACEA BIOTECH  NATCO PHARMA  FRESENIUS KABI ONCO.  SHASUN PHARMA  LUPIN  

Compare ALKEM LABORATORIES With:   PANACEA BIOTECH  NATCO PHARMA  FRESENIUS KABI ONCO.  SHASUN PHARMA  LUPIN  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  




Today's Market

Sensex Ends Flat; Maruti Suzuki Rallies 7.5%(Closing)

After opening the day at record high levels, Indian share markets erased gains as the session progressed and ended on a flat note, led by a decline in IT stocks and index heavyweight HDFC Bank.

Views on news

Most Popular

Not Infosys or Wipro. India's Next Wealth Creators Could Be Drone Stocks (Profit Hunter)

Nov 25, 2020

India's drones directorate signals the next big defence tech multibaggers.

It's Time to Book Profits (Fast Profits Daily)

Nov 27, 2020

In my first video on Equitymaster, I want to introduce you my proprietary greed and fear index. It's telling us to book some profits in the market.

How the New Margins Will Impact You (Fast Profits Daily)

Nov 25, 2020

The new rules on margins will come into effect from 1st December. Are you ready?

Create Wealth for Yourself in India's Drone Revolution (Profit Hunter)

Nov 27, 2020

The Chinese drone market is 14 times that of India's. Billions may flow into Indian drone companies too. Don't miss out on this wealth creating opportunity.

The Price of Dying, the Cost of Living (The Honest Truth)

Nov 20, 2020

Ajit Dayal presents a cost benefit analysis of the various types of response to covid around the world.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS